Covid-19 Vaccine Stocks

<p>CFRA has a buy rating on the Pfizer (PFE) stock with a $45 price target. They also have a buy rating on Johnson &amp; Johnson (JNJ) with a $177 price target, as well as Novavax (NVAX) with a $200 price target. Sel Hardy examines the outlook for these pharmaceutical stocks.</p>